Allucent
↗Cary, North Carolina, USA
Allucent is a global, science-centric Contract Research Organization (CRO) purpose-built to support the distinct needs of small and mid-sized biopharmaceutical companies. The company provides comprehensive drug development solutions, including clinical trial management, regulatory strategy, medical writing, and clinical pharmacology.
Formed through the strategic merger of CATO SMS and Pharm-Olam, Allucent leverages over 30 years of experience to help innovators navigate the complexities of drug development. The company operates in more than 60 countries, offering a high-touch partnership model that combines global reach with the agility required by emerging biotech firms.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Trial Management & Regulatory Consulting
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$400M-$500M
Founded:1988
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$129M+
Investors:JLL Partners, Water Street Healthcare Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CRO Services)
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, Radiopharmaceuticals
Active Trials:450
Trial Phases:Phase 1: 120 | Phase 2: 180 | Phase 3: 100 | Phase 4: 50
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pharm-Olam, Nuventra, Array Biostatistics, Advyzom
Key Partnerships:Silo Pharma (PTSD drug SPC-15 development), Veeva Systems (CRO Partner Program), Medidata (Technology partner)
COMPETITION
Position:Leader
Competitors:Medpace, ICON plc, IQVIA, Parexel, PPD (Thermo Fisher Scientific)
LEADERSHIP
Key Executives:
Paula Brown Stafford - CEO
Patrick Phillips - COO
Mark A. Goldberg - Chairman
Scientific Founders:Allen Cato (Founder of Cato Research)
Board Members:Mark A. Goldberg, Paula Brown Stafford
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Allucent. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.